ESR1 and breast carcinoma: We show real-world patient data from two pathology laboratories in Germany to highlight the rarity of ESR1 mutations, discuss different molecular approaches to detect them, and show a general distribution and pattern of occurrence of these mutations in a cohort of 354 breast cancer patients as detected by our NGS panel.